UNSPSC 85516180: Occlusion of right femoral artery with extraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of right femoral artery with extraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04LK4CZ

UNSPSC 85516180, Occlusion of right femoral artery with extraluminal device, percutaneous endoscopic approach, is a Commodity code describing a specific interventional vascular procedure. However, the code shows minimal alignment with actual state and local procurement activity. Recent opportunities tagged under this code do not reflect vascular device procurement or implant supply; instead, they document contracts for medical services, benefit administration, occupational health surveillance, and health professional staffing—none of which involves the femoral artery occlusion devices the code nominally describes. State and local bodies issuing under this code span city retirement offices, county human resources and juvenile probation departments, regional health systems, and state transportation agencies, but the mismatch between the code's procedure-specific name and the actual services being procured suggests either systematic miscoding of these opportunities or that the code is rarely used for its intended scope.

The most recent opportunities posted under this code include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026), the City of Long Beach's RFP for surgical benefit carve-out management (due October 7, 2026), the Washington State Department of Transportation's RFQ for occupational medical surveillance services (due October 9, 2026), and Collier County's RFP for pharmacy benefit management services (due April 9, 2026). These solicitations span Arizona, California, Washington, and Florida, but their substance—disability evaluations, bundled surgical networks, occupational health exams, and pharmacy claims administration—bears no operational relationship to vascular interventional devices. The code presents no clear signal of active procurement for its stated commodity class; business development professionals should verify coding accuracy before committing resources to this classification.